Objective: The aim of this study was to retrospectively compare early and late results of aortobifemoral bypass and endovascular recanalization with the kissing stent technique in the management of TransAtlantic Inter-Society Consensus II (TASC II) C and D lesions in the aortoiliac district in a multicenter study.
Aortobifemoral (AbF) bypass grafting and open endarterectomy remain effective and durable treatment options for aortoiliac occlusive disease (AIOD), but in the most recent years, endovascular revascularization has been used increasingly as an alternative to conventional surgery with good clinical results. [1] [2] [3] In particular, the "kissing stent"
technique has been proposed for the treatment of complex aortoiliac lesions; it is particularly attractive for patients with high surgical risk because complications and mortality of AbF bypass still remain significant issues. [4] [5] [6] [7] Moreover, in more complex disease patterns, such as those with the obstruction extending beyond or those with an associated severe femoral artery disease, hybrid technique using femoral artery endarterectomy in combination with aortoiliac kissing stents has emerged to extend the applicability of an endovascular approach. [8] [9] [10] [11] From Thus, optimal management of AIOD is still under debate. AbF bypass proved to have durable results, but kissing stent series showed fewer postoperative complications and good durability with results resembling those of open surgery, and operative options are not lost even if kissing stents have failed. However, few studies have directly compared AbF bypass grafting and the kissing stent technique, often including patients with heterogeneous clinical conditions. [11] [12] [13] [14] The purpose of this study was to retrospectively compare the early and late outcomes of AbF bypass grafting vs kissing stents in the treatment of complex AIOD.
METHODS
Study group. From January 2006 to December 2013, 461 open and endovascular interventions for AIOD were performed in three teaching hospitals. Data concerning these interventions were prospectively recorded in the certified institutional registry at each participating center. Informed consent for the treatment of personal data was acquired for each patient for insertion in the prospective registry, but the retrospective analysis of the data did not require approval of the Institutional Review Board.
Starting from January 2014, the data of each center were retrospectively merged in only one created in the coordinator center and containing main anatomic, clinical, diagnostic, and technical variables. This database also contained perioperative (<30 days) results and all relevant clinical and diagnostic data collected during follow-up. There were 293 interventions performed for TransAtlantic Inter-Society Consensus (TASC II) classification C and D lesions 15 ; patients who underwent open or endovascular unilateral treatment were excluded from the analysis. Therefore, the remaining 210 interventions performed for aortic or bilateral iliac involvement formed our study group. Interventions consisted of surgical AbF bypass grafting in 82 cases (39%, group 1) and the kissing stent technique in 128 cases (61%, group 2).
Diagnostic workup and surgical technique. Preoperative diagnostic assessment consisted of ankle-brachial index (ABI) measurement and duplex ultrasound scanning and computed tomography angiography of the aorta and iliac-femoral axis in all the cases. Patients were operated on in the presence of severe lifestyle-limiting intermittent claudication after the failure of other conservative measures or in the presence of critical limb ischemia (CLI). The anatomic indication for open intervention has substantially changed during the years. Whereas in the first years of the examined period AbF bypass was performed in patients with occlusion or subocclusion of the terminal aorta and of the iliac axes, open surgical revascularization was reserved in the most recent period for patients with total occlusion of the infrarenal aorta starting from just below the origin of the renal arteries, for patients with severe and diffuse calcification of the aorta and iliac arteries, and for less complex lesions after the failure of a previous endovascular attempt. On the other hand, a progressive widening of the indications for endovascular treatment occurred, from iliac lesions with minimal aortic involvement in the first years to more complex lesions in recent years; nowadays, all the patients undergo a preoperative feasibility assessment for an endovascular primary approach. Moreover, the general condition of the patients has also been taken into account in choosing one operative strategy; in patients with severe comorbidities, an endovascular approach even in the presence of extensive aortoiliac disease has often been considered. The annual trend of the interventions in the examined period is shown in Fig 1. Open surgical interventions were performed in the operating room under general anesthesia with standard technique with a transperitoneal approach to the aortoiliac axis and a longitudinal approach to the femoral bifurcations. A bifurcated graft with an end-to-side aortic anastomosis was used in all the cases. The distal anastomoses were performed in an end-to-side fashion at the level of the distal common femoral artery. In selected patients with concomitant occlusive disease of the femoral bifurcation and of the superficial femoral artery, endarterectomy of the bifurcation was carried out and the distal anastomosis was extended into the proximal deep femoral artery.
Kissing stents were performed by the same vascular surgeons in the operating room or in the angiographic suite on the basis of local facilities; local anesthesia was supplemented with intravenous sedation or analgesia when required. A standard technique of arterial access with a unilateral or bilateral femoral approach was preferentially used; concomitant left brachial access was used in selected cases. In case of complex lesions involving the femoral bifurcation, a hybrid approach was performed; in all cases, femoral endarterectomy was closed with a silver-bonded Dacron or pericardial or polyurethane patch. At that time, we punctured the center of the patch, and a retrograde working sheath was placed once inflow had been restored. An intraluminal technique of arterial recanalization was initially attempted whenever possible. In case of long occlusions, a subintimal recanalization with a brachial approach was often unavoidable. After arterial recanalization, a standard kissing stent technique was performed, with the placement of the proximal stent ends at a higher level than the aortic bifurcation or the proximal extension of the lesion. 7 In general, we do not cross the inguinal ligament with the distal edge of the stents to avoid fractures. Our policy was to use self-expanding stents for lesions between 2 and 10 cm in length. Balloon-expandable stents were used preferentially for focal, ostial, and severely calcified lesions. Self-expanding covered stents were preferentially used for long obstructive segments, when the ipsilateral hypogastric artery was occluded, or for severely calcified lesions. All patients received shortterm antibiotic prophylaxis at induction and heparinization (40 IU/kg) at the beginning of the endovascular procedure or just before femoral clamping. Postoperatively, group 1 was prescribed single antiplatelet therapy ad infinitum; patients in group 2 usually had double antiplatelet treatment for at least 24 months and single antiplatelet treatment thereafter; warfarin was continued when it was already used preoperatively. Follow-up included clinical visit with ABI and duplex ultrasound examination at 6-month intervals during the first year and once per year thereafter. During ultrasound examinations, the patency of the treated vessels and the status of the inflow and outflow arteries were assessed. Significant (>70%) restenosis of the treated segment was defined as a significant increase of the peak systolic velocity at the stenotic site >250 cm/s; occlusion was defined as absence of flow into the treated vessels.
Computed tomography angiography was performed in such cases and if symptoms were suspected for a recurrent aortoiliac disease as well.
Definitions. Comorbidities and risk factors were defined as previously described. 2, 7 The aortoiliac-femoral lesion was defined according to the TASC II classification, and the clinical status was defined according to the Rutherford classification. 15 Early (intraoperative and <30 days) results were analyzed in terms of death, thrombosis, reinterventions, and occurrence of major local and systemic complications defined according to recommended standards for reports dealing with lower extremity ischemia. 16 In group 2, we assessed technical success, defined as a <20% residual stenosis at completion angiography, and conversion to open surgery, defined as technical failure followed by immediate surgical repair.
Primary patency was defined as uninterrupted patency without procedures performed on or at the margin of the treated segment. Loss of patency was diagnosed when ABI deterioration was associated with duplex ultrasound evidence of significant restenosis, requiring or not a secondary intervention to maintain arterial patency, or thrombosis of the treated segment. Follow-up results were analyzed in terms of survival, primary and secondary patency (defined as restored patency through the original treated segment), assisted primary patency (defined as the success of procedures carried out on a still patent segment to prevent its thrombosis), and freedom from reinterventions. Table I .
RESULTS
Clinical and morphologic data. Demographic data, comorbidities, and risk factors are shown in Table II . Briefly, mean age was similar, but in group 2, there were more men than in group 1 as well as a more frequent history of arterial hypertension and diabetes mellitus.
All the patients had a TASC II C and D lesion at the time of the intervention. Patients in group 1 had a TASC II D lesion in most cases; among patients in group 2, a TASC II C lesion was present in about 40% of the cases (Table III) . The frequency of TASC II C and D lesions in group 2 during the years is shown in Fig 2. Among patients in group 1, aortic involvement was present in 77 patients, whereas five patients had isolated bilateral iliac disease. Among the former, concomitant unilateral or bilateral iliac occlusion was present in 74 cases; three patients had bilateral iliac stenoses. Among the five patients without aortic involvement, three had bilateral iliac occlusion and two had diffuse bilateral stenoses at the level of the common and external iliac arteries. In group 2, four patients had a complete occlusion of the infrarenal aorta and of both common iliac arteries. In 61 cases, stenotic involvement of the terminal aorta was present with concomitant iliac disease; in the remaining cases, only bilateral iliac stenoses or occlusions were present.
Overall, unilateral or bilateral iliac occlusion was present in 94% of patients in group 1 (77 cases) and in 67% of patients (86 cases) in group 2 (P < .001). In group 1, five patients were operated on after the late failure of a previous endovascular intervention (unilateral iliac stenting in three cases and bilateral iliac stenting in the remaining two); in one case, the intervention was performed after a previous failed bilateral femoral endarterectomy and patching. These patients were not part of group 2 as they had been operated on in other hospitals (two cases) or in the participating hospitals before the beginning of the study period (three cases). All the patients in group 2 had a primary intervention.
Preoperative mean ABI was 0.27 6 0.17 in group 1 and 0.44 6 0.21 in group 2 (P ¼ .06).
Technical details. In group 1, all the interventions consisted of an AbF bypass, Dacron in 57 (69.5%; silver impregnated, n ¼ 2) and expanded polytetrafluoroethylene in the remaining 25 (30.5%). Unilateral or bilateral endarterectomy with patching of the femoral arteries was performed in 12 cases. In two patients, concomitant unilateral below-the-knee femoropopliteal bypass graft was performed. In group 2, all patients had kissing stents at the aortic bifurcation; ipsilateral and contralateral percutaneous femoral access was used in 83 cases, whereas a concomitant percutaneous left brachial access was used in 32. The remaining 13 patients had a The mean length of the stented iliac arteries was 15.5 6 9.5 cm. In 84 cases, two stents were just placed at the iliac aortic bifurcation; in the remaining 44 cases, a mean number of 2.7 stents were used down the common into the external iliac artery. Concomitant associated open surgical intervention was performed in six patients and consisted of femoral endarterectomy and patching in all the cases. In one case, concomitant renal angioplasty and stenting for a severe right renal artery stenosis was performed.
Early (<30 days) results. In group 2, technical success was 98.5% (n ¼ 126); two patients, one operated on for intermittent claudication and one for rest pain, required intraoperative conversion to open surgery for iliac rupture. One perioperative death in group 1 was due to acute myocardial infarction (mortality rate, 1%). Four cases of perioperative thrombosis occurred, two in each group (2% vs 1.5%; P ¼ .6). In group 1, thrombosis occurred at postoperative days 12 and 20; in both cases, the patients had been operated on for rest pain, and the complication was treated with a new bypass graft. In group 2, one unilateral stent thrombosis occurred at postoperative day 2, and it was successfully treated with surgical thrombectomy; one patient had a bilateral stent thrombosis at postoperative day 7 that required conversion to AbF bypass. Both patients had been operated on for intermittent claudication. No amputations were performed. Local complications occurred in seven cases in group 1 (8.5%) and in six cases in group 2 (5%; P ¼ .03); the kind and distribution of intraoperative and perioperative local complications are listed in Table IV . Major morbidity occurred in 10 cases in group 1 (12%) and in three cases in group 2 (2%; P ¼ .006; Table IV ). The overall rate of perioperative complications, excluding thromboses, was 20.5% (17 patients) in group 1 and 7% (9 patients) in group 2 (P < .001).
At 30 days, mean ABI was 0.82 6 0.16 in group 1 and 0.91 6 0.13 in group 2 (P ¼ .08).
Follow-up results. All patients who survived the operation entered the follow-up; mean duration of follow-up was 38.1 months (range, 1-96), and 199 (94.5%) patients had regular postoperative follow-up visits. The mean cumulative follow-up index for survival was 0.68 (range, 0.05-1), and it was similar between the two groups (0.65 6 0.29 in group 1 and 0.7 6 0.28 in group 2; P ¼ .9). During follow-up, 26 deaths occurred, 13 in each group. Estimated 72-month survival rates were 65.5% (standard error [SE] , 0.08) in group 1 and 83.5% (SE, 0.05) in group 2 (P ¼ .1; log-rank, 2.4).
Significant restenosis of the treated vessel occurred in two cases in group 2, successfully treated in both patients with a new endovascular procedure. Eleven thromboses were recorded during follow-up, 1 in group 1 and 10 in group 2. The patient in group 1, operated on for CLI, at 13 months developed a right iliac limb thrombosis, successfully treated with surgical thrombectomy and femoral patching. In group 2, five thromboses occurred in patients operated on for intermittent claudication (one case) and for CLI (four cases) and were successfully treated with a new endovascular procedure; in five cases, the occlusion led to mild claudication and the patients were medically managed. There were no conversions to open surgery among patients of group 2.
Primary patency rates at 6 years were 95.5% (SE, 0.03) in group 1 and 83% (SE, 0.04) in group 2 (P ¼ .07; log-rank, 3.3). The corresponding rates of assisted primary patency were 95.5% (SE, 0.03) and 86% (SE, 0.05), respectively (P ¼ .1; log-rank, 2.2). Estimated secondary patency rates at 72 months were 97% (SE, 0.2) in group 1 and 93% (SE, 0.03) in group 2 (P ¼ .6; log-rank, 0.2). At the same time interval, freedom from reinterventions was 94% (SE, 0.03) in group 1 and 89% (SE, 0.04) in group 2 (P ¼ .3; log-rank, 0.8). No amputations were recorded in both groups. Kaplan-Meier curves for long-term outcomes are reported in Fig 3. Univariate analysis for factors affecting primary patency in the whole study group is reported in Table V . At Cox regression analysis, only the presence of CLI was independently associated with poorer primary patency during follow-up (hazard ratio, 2.4; 95% confidence interval, 0.9-6.4; P ¼ .05).
DISCUSSION
Both AbF bypass grafting and the kissing stent technique are commonly performed, but only a few studies have addressed a direct comparison because of the difficulty in matching these patients. 18, 19 This study is the analysis of two recent cohorts of patients treated in referral centers in a short period of inclusion compared with the similar published papers. [11] [12] [13] [14] Volume at the physician and hospital levels appears to be a robust predictor of patient outcomes after AIOD treatment, either for open surgery or for endovascular intervention. 19, 20 Despite a progressive decrease in the number of AbF bypass grafts per year, Patel et al showed that with only minor exception, endovascular surgery has not appreciably increased the complexity of open aortic operations performed for AIOD. 21 Our experience is in line with these findings. We have high-volume programs for both of these interventions, and although our patients were not randomized, we observed no drastic differences in outcome between these two therapies.
The ongoing debate on the optimal operative management of complex AIOD is related to which of these two techniques is superior in terms of clinical and operative outcomes. The durability of the AbF bypass is offset by the low rate of morbidity and mortality of the kissing stent technique, which on the contrary has been questioned in terms of long-term patency and need of reinterventions. 19, [21] [22] [23] A recent review showed that AbF bypass grafting had a higher mortality than the kissing stent technique; that study highlighted the impact of the higher incidences of coronary and respiratory diseases in patients undergoing open repair. 19 This was surprising, probably because of the fact that anatomically suitable lesions were preferentially treated with the kissing stent technique regardless of the patients' comorbidities. 11, 12 Our data combine these two observations; although cardiorespiratory risk factors were homogeneously distributed in the two groups, we can confirm that mortality and major morbidity were mainly hampered by cardiac events. This finding deserves a comment. Danczyk et al reported a better survival in patients undergoing redo AbF bypass grafting compared with those undergoing primary operation despite a higher percentage of cardiac risk factors. 24 The reason that a much more invasive operation has better clinical outcomes lies in the fact that redo patients, at that time, were on a better medical regimen; this may underline the importance on outcomes during primary operation, and it could be a coexplanation of the literature and personal results. Last but not least, it confirms that in contrast to infrainguinal distal revascularization, endovascular-first treatment does not preclude an effective open rescue; this is also supported by the findings of Patel et al, who demonstrated that endovascular surgery has not appreciably increased the complexity of open aortic operations performed for AIOD. 21 When we consider cardiovascular risk factors and their impact on clinical outcomes, we should take into account that most of these patients presented with a more important severity of ischemia. 11, 14, 19 Among factors influencing postoperative outcomes, CLI is a known marker of poorer results. 15 This holds true also in our study; CLI was an independent risk factor for worse outcomes. Although AbF bypass grafting and kissing stent technique patencies did not differ in the long run, overall patency results were negatively affected by CLI. Our data find support in another study of Kashyap et al, who showed that the status of the runoff vessels is another important factor negatively affecting the patency of such interventions. 11 In their experience, patients who required concomitant distal revascularization along with either AbF bypass or kissing stents had dismal patency rates, reflecting the more severe atherosclerotic burden in a patient with CLI. Considering the durability of these two types of treatment, long-term survival is another primary end point to be evaluated. Disappointingly, it is not surprising to find conflicting data. Kashyap et al reported a survival rate of 80% at 3 years in both groups; Sachwani et al had results at 6 years with 76% survival for AbF bypass and 68% for kissing stents. 11, 14 At the same time point, our results are exactly the opposite, with better survival for the endovascular group, independent of the initial age of patients in the two groups. Considering longterm survival, we should underline that our study is consistent with many series of interventions for complex AIOD in which most patients were treated for claudication rather than for CLI. [11] [12] [13] [14] 19 One possible explanation for the better survival in group 2 is represented by the different long-term postoperative regimen, with a wide use of double antiplatelet treatment in the endovascular group, probably favoring a better control of cardiovascular events during the years. Primary, assisted primary, and secondary patency rates were similar between the two groups; there was, however, a trend toward better results for patients in group 1, particularly when primary and assisted primary patency were examined. This is a common finding in the prior vascular literature, and in this study it could be due to type II statistical errors. 19 One can suppose that with a larger number of patients and a longer follow-up time, the difference could become significant; however, all the patients needing a reintervention in group 2 were treated with a novel endovascular approach, allowing the gap between the two groups to be further reduced in terms of secondary patency.
Limitations. Limitations of our study are worthy of mention and inherent to the study design. This is a retrospective nonrandomized study, with heterogeneous criteria for the choice of the treatment and progressive changes in indications during the years. Moreover, we had a higher percentage of more complex lesions in group 1, even if the cumulative number of TASC II C and D lesions was similar in the groups. Furthermore, we did not perform an analysis on costs and postoperative sexual dysfunction. On the other hand, the two groups matched well under a clinical point of view, and the mild anatomic differences between them did not affect late outcomes; moreover, it involves referral centers with a large number of treated cases, and follow-up was consistent, allowing assessment of durability and survival.
CONCLUSIONS
Endovascular repair of aortoiliac complex lesions with the kissing stent technique in suitable patients in this multicenter experience provided satisfactory early and late results similar to those obtained with open aortofemoral bypass surgery. The rate of perioperative complications was lower in patients undergoing endovascular treatment, and there was a trend toward better longterm survival. The numerically higher rate of reintervention over the time observed in endovascularly treated patients is mitigated by the fact that most of the longterm complications were successfully treated with another endovascular procedure. 
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